Polygenic risk scores for predicting outcomes and treatment response in psychiatry: hope or hype?

References

• Alda, M. (2017). Who are excellent lithium responders and why do they matter? World Psychiatry, 16(3), 319–320. https://doi.org/10.1002/wps.20462
   PubMed Web of Science ®Google Scholar
• Amare, A. T., Schubert, K. O., Hou, L., Clark, S. R., Papiol, S., Cearns, M., Heilbronner, U., Degenhardt, F., Tekola-Ayele, F., Hsu, Y.-H., Shekhtman, T., Adli, M., Akula, N., Akiyama, K., Ardau, R., Arias, B., Aubry, J.-M., Backlund, L., Bhattacharjee, A. K., … Baune, B. T. (2021). Association of polygenic score for major depression with response to lithium in patients with bipolar disorder. Molecular Psychiatry, 26(6), 2457–2470. https://doi.org/10.1038/s41380-020-0689-5
   PubMed Web of Science ®Google Scholar
• Amare, A. T., Schubert, K. O., Tekola-Ayele, F., Hsu, Y.-H., Sangkuhl, K., Jenkins, G., Whaley, R. M., Barman, P., Batzler, A., Altman, R. B., Arolt, V., Brockmöller, J., Chen, C.-H., Domschke, K., Hall-Flavin, D. K., Hong, C.-J., Illi, A., Ji, Y., Kampman, O., … Baune, B. T. (2018). Association of the polygenic scores for personality traits and response to selective serotonin reuptake inhibitors in patients with major depressive disorder. Frontiers in Psychiatry, 9, 65. https://doi.org/10.3389/fpsyt.2018.00065
   PubMed Web of Science ®Google Scholar
• Amare, A. T., Schubert, K. O., Tekola-Ayele, F., Hsu, Y.-H., Sangkuhl, K., Jenkins, G., Whaley, R. M., Barman, P., Batzler, A., Altman, R. B., Arolt, V., Brockmöller, J., Chen, C.-H., Domschke, K., Hall-Flavin, D. K., Hong, C.-J., Illi, A., Ji, Y., Kampman, O., … Baune, B. T. (2019). The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression. Journal of Neural Transmission, 126(1), 35–45. https://doi.org/10.1007/s00702-018-01966-x
   PubMed Web of Science ®Google Scholar
• Belbin, G. M., Cullina, S., Wenric, S., Soper, E. R., Glicksberg, B. S., Torre, D., Moscati, A., Wojcik, G. L., Shemirani, R., Beckmann, N. D., Cohain, A., Sorokin, E. P., Park, D. S., Ambite, J.-L., Ellis, S., Auton, A., Bottinger, E. P., Cho, J. H., Loos, R. J. F., … Kenny, E. E. (2021). Toward a fine-scale population health monitoring system. Cell, 184(8), 2068–2083. https://doi.org/10.1016/j.cell.2021.03.034
   PubMed Web of Science ®Google Scholar
• Burkhard, C., Cicek, S., Barzilay, R., Radhakrishnan, R., & Guloksuz, S. (2021). Need for ethnic and population diversity in psychosis research. Schizophrenia Bulletin, 47(4), 889–895. https://doi.org/10.1093/schbul/sbab048
   PubMed Web of Science ®Google Scholar
• Cearns, M., Amare, A. T., Schubert, K. O., Thalamuthu, A., Frank, J., Streit, F., Adli, M., Akula, N., Akiyama, K., Ardau, R., Arias, B., Aubry, J.-M., Backlund, L., Bhattacharjee, A. K., Bellivier, F., Benabarre, A., Bengesser, S., Biernacka, J. M., Birner, A., … Baune, B. T. (2022). Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: Machine learning approach. British Journal of Psychiatry. Advance online publication. https://doi.org/10.1192/bjp.2022.28
   Web of Science ®Google Scholar
• Choi, S. W., Mak, T. S.-H., & O’Reilly, P. F. (2020). Tutorial: A guide to performing polygenic risk score analyses. Nature Protocols, 15(9), 2759–2772. https://doi.org/10.1038/s41596-020-0353-1
   PubMed Web of Science ®Google Scholar
• Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., Chaib, H., Merker, J. D., Goldfeder, R. L., Enns, G. M., David, S. P., Pakdaman, N., Ormond, K. E., Caleshu, C., Kingham, K., Klein, T. E., Whirl-Carrillo, M., Sakamoto, K., Wheeler, M. T., Butte, A. J., … Quertermous, T. (2014). Clinical interpretation and implications of whole-genome sequencing. JAMA, 311(10), 1035–1045. https://doi.org/10.1001/jama.2014.1717
   PubMed Web of Science ®Google Scholar
• Erzin, G., Pries, L.-K., Dimitrakopoulos, S., Ralli, I., Xenaki, L.-A., Soldatos, R.-F., Vlachos, I., Selakovic, M., Foteli, S., Kosteletos, I., Nianiakas, N., Mantonakis, L., Rizos, E., Kollias, K., Van Os, J., Guloksuz, S., & Stefanis, N. (2021). Association between exposome score for schizophrenia and functioning in first-episode psychosis: Results from the Athens first-episode psychosis research study. Psychological Medicine. Avance online publication. https://doi.org/10.1017/S0033291721004542
   PubMedGoogle Scholar
• Erzin, G., Pries, L.-K., van Os, J., Fusar-Poli, L., Delespaul, P., Kenis, G., Luykx, J. J., Lin, B. D., Richards, A. L., Akdede, B., Binbay, T., Altınyazar, V., Yalınçetin, B., Gümüş-Akay, G., Cihan, B., Soygür, H., Ulaş, H., Cankurtaran, E. Ş., Kaymak, S. U., … Guloksuz, S. (2021). Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. European Psychiatry, 64(1), e25. https://doi.org/10.1192/j.eurpsy.2021.19
   PubMed Web of Science ®Google Scholar
• Fabbri, C., Hagenaars, S. P., John, C., Williams, A. T., Shrine, N., Moles, L., Hanscombe, K. B., Serretti, A., Shepherd, D. J., Free, R. C., Wain, L. V., Tobin, M. D., & Lewis, C. M. (2021). Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts. Molecular Psychiatry, 26(7), 3363–3373. https://doi.org/10.1038/s41380-021-01062-9
   PubMed Web of Science ®Google Scholar
• Fanelli, G., Benedetti, F., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G., Ferentinos, P., Rujescu, D., Mendlewicz, J., Serreti A., & Fabbri, C. (2021). Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 108, 110170. https://doi.org/10.1016/j.pnpbp.2020.110170
   PubMed Web of Science ®Google Scholar
• Fanelli, G., Domschke, K., Minelli, A., Gennarelli, M., Martini, P., Bortolomasi, M., Maron, E., Squassina, A., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G., Ferentinos, P., Rujescu, D., Mendlewicz, J., De Ronchi, D., Baune, B. T., Serretti, A., … Fabbri, C. (2022). A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response. European Neuropsychopharmacology, 55, 86–95. https://doi.org/10.1016/j.euroneuro.2021.11.005
   PubMed Web of Science ®Google Scholar
• Ferrara, M., & Srihari, V. H. (2021). Early intervention for psychosis in the United States: Tailoring services to improve care for women. Psychiatric Services, 72(1), 5–6. https://doi.org/10.1176/appi.ps.202000205
   PubMed Web of Science ®Google Scholar
• Foo, J. C., Streit, F., Frank, J., Witt, S. H., Treutlein, J., Baune, B. T., Moebus, S., Jöckel, K.-H., Forstner, A. J., Nöthen, M. M., Rietschel, M., Sartorius, A., & Kranaster, L. (2019). Evidence for increased genetic risk load for major depression in patients assigned to electroconvulsive therapy. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 180(1), 35–45. https://doi.org/10.1002/ajmg.b.32700
   PubMed Web of Science ®Google Scholar
• Frank, J., Lang, M., Witt, S. H., Strohmaier, J., Rujescu, D., Cichon, S., Degenhardt, F., Nöthen, M. M., Collier, D. A., Ripke, S., Naber, D., & Rietschel, M. (2015). Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients. Molecular Psychiatry, 20(2), 150–151. https://doi.org/10.1038/mp.2014.56
   PubMed Web of Science ®Google Scholar
• García-González, J., Tansey, K. E., Hauser, J., Henigsberg, N., Maier, W., Mors, O., Placentino, A., Rietschel, M., Souery, D., Žagar, T., Czerski, P. M., Jerman, B., Buttenschøn, H. N., Schulze, T. G., Zobel, A., Farmer, A., Aitchison, K. J., Craig, I., McGuffin, P., … Fabbri, C. (2017). Pharmacogenetics of antidepressant response: A polygenic approach. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 75, 128–134. https://doi.org/10.1016/j.pnpbp.2017.01.011
   PubMed Web of Science ®Google Scholar
• Gibson, G. (2019). On the utilization of polygenic risk scores for therapeutic targeting. PLoS Genetics, 15(4), e1008060. https://doi.org/10.1371/journal.pgen.1008060
   PubMed Web of Science ®Google Scholar
• Girgus, J. S., & Yang, K. (2015). Gender and depression. Current Opinion in Psychology, 4, 53–60. https://doi.org/10.1016/j.copsyc.2015.01.019
   Web of Science ®Google Scholar
• Gottesman, I. I., & Shields, J. (1967). A polygenic theory of schizophrenia. Proceedings of the National Academy of Sciences, 58(1), 199–205. https://doi.org/10.1073/pnas.58.1.199
   PubMed Web of Science ®Google Scholar
• Guloksuz, S., & van Os, J. (2018). The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum. Psychological Medicine, 48(2), 229–244. https://doi.org/10.1017/S0033291717001775
   PubMed Web of Science ®Google Scholar
• Guloksuz, S., & van Os, J. (2020). Dr. Strangelove, or how we learned to stop worrying and love uncertainty. World Psychiatry, 19(3), 395–396. https://doi.org/10.1002/wps.20794
   PubMed Web of Science ®Google Scholar
• Guloksuz, S., Pries, L.-K., Ten Have, M., de Graaf, R., van Dorsselaer, S., Klingenberg, B., Bak, M., Lin, B. D., van Eijk, K. R., Delespaul, P., van Amelsvoort, T., Luykx, J. J., Rutten, B. P. F., & van Os, J. (2020). Association of preceding psychosis risk states and non-psychotic mental disorders with incidence of clinical psychosis in the general population: A prospective study in the NEMESIS-2 cohort. World Psychiatry, 19(2), 199–205. https://doi.org/10.1002/wps.20755
   PubMed Web of Science ®Google Scholar
• Guloksuz, S., Rutten, B. P. F., Pries, L.-K., Ten Have, M., de Graaf, R., van Dorsselaer, S., Klingenberg, B., van Os, J., & Ioannidis, J. P. A. (2018). The complexities of evaluating the exposome in psychiatry: A data-driven illustration of challenges and some propositions for amendments. Schizophrenia Bulletin, 44(6), 1175–1179. https://doi.org/10.1093/schbul/sby118
   PubMed Web of Science ®Google Scholar
• Guloksuz, S., van Os, J., & Rutten, B. P. F. (2018). The exposome paradigm and the complexities of environmental research in psychiatry. JAMA Psychiatry, 75(10), 985–986. https://doi.org/10.1001/jamapsychiatry.2018.1211
   PubMed Web of Science ®Google Scholar
• Haq, A. U., Sitzmann, A. F., Goldman, M. L., Maixner, D. F., & Mickey, B. J. (2015). Response of depression to electroconvulsive therapy: A meta-analysis of clinical predictors. The Journal of Clinical Psychiatry, 76(10), 1374–1384. https://doi.org/10.4088/JCP.14r09528
   PubMed Web of Science ®Google Scholar
• Harrow, M., Grossman, L. S., Jobe, T. H., & Herbener, E. S. (2005). Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. Schizophrenia Bulletin, 31(3), 723–734. https://doi.org/10.1093/schbul/sbi026
   PubMed Web of Science ®Google Scholar
• Hilker, R., Helenius, D., Fagerlund, B., Skytthe, A., Christensen, K., Werge, T. M., Nordentoft, M., & Glenthøj, B. (2018). Heritability of schizophrenia and schizophrenia spectrum based on the nationwide Danish Twin Register. Biological Psychiatry, 83(6), 492–498. https://doi.org/10.1016/j.biopsych.2017.08.017
   PubMed Web of Science ®Google Scholar
• Howard, D. M., Adams, M. J., Clarke, T.-K., Hafferty, J. D., Gibson, J., Shirali, M., Coleman, J. R. I., Hagenaars, S. P., Ward, J., Wigmore, E. M., Alloza, C., Shen, X., Barbu, M. C., Xu, E. Y., Whalley, H. C., Marioni, R. E., Porteous, D. J., Davies, G., Deary, I. J., … McIntosh, A. M. (2019). Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nature Neuroscience, 22(3), 343–352. https://doi.org/10.1038/s41593-018-0326-7
   PubMed Web of Science ®Google Scholar
• Ioannidis, J. P. (2005). Why most published research findings are false. PLoS Medicine, 2(8), e124. https://doi.org/10.1371/journal.pmed.0020124
   PubMed Web of Science ®Google Scholar
• Ioannidis, J. P. (2008). Why most discovered true associations are inflated. Epidemiology, 19(5), 640–648. https://doi.org/10.1097/EDE.0b013e31818131e7
   PubMed Web of Science ®Google Scholar
• Janssens, A. C. J. W. (2019). Validity of polygenic risk scores: Are we measuring what we think we are? Human Molecular Genetics, 28(R2), R143–R150. https://doi.org/10.1093/hmg/ddz205
   PubMed Web of Science ®Google Scholar
• Jonas, K. G., Lencz, T., Li, K., Malhotra, A. K., Perlman, G., Fochtmann, L. J., Bromet, E. J., & Kotov, R. (2019). Schizophrenia polygenic risk score and 20-year course of illness in psychotic disorders. Translational Psychiatry, 9(1), 300. https://doi.org/10.1038/s41398-019-0612-5
   PubMedGoogle Scholar
• Jones, H. J., Stergiakouli, E., Tansey, K. E., Hubbard, L., Heron, J., Cannon, M., Holmans, P., Lewis, G., Linden, D. E. J., Jones, P. B., Davey Smith, G., O’Donovan, M. C., Owen, M. J., Walters, J. T., & Zammit, S. (2016). Phenotypic manifestation of genetic risk for schizophrenia during adolescence in the general population. JAMA Psychiatry, 73(3), 221–228. https://doi.org/10.1001/jamapsychiatry.2015.3058
   PubMed Web of Science ®Google Scholar
• Landi, I., Kaji, D. A., Cotter, L., Van Vleck, T., Belbin, G., Preuss, M., Loos, R. J. F., Kenny, E., Glicksberg, B. S., Beckmann, N. D., O’Reilly, P., Schadt, E. E., Achtyes, E. D., Buckley, P. F., Lehrer, D., Malaspina, D. P., McCarroll, S. A., Rapaport, M. H., Fanous, A. H., … Charney, A. W. (2021). Prognostic value of polygenic risk scores for adults with psychosis. Nature Medicine, 27(9), 1576–1581. https://doi.org/10.1038/s41591-021-01475-7
   PubMed Web of Science ®Google Scholar
• Lewis, C. M., & Vassos, E. (2020). Polygenic risk scores: From research tools to clinical instruments. Genome Medicine, 12(1), 44. https://doi.org/10.1186/s13073-020-00742-5
   PubMed Web of Science ®Google Scholar
• Li, Q. S., Wajs, E., Ochs-Ross, R., Singh, J., & Drevets, W. C. (2020). Genome-wide association study and polygenic risk score analysis of esketamine treatment response. Scientific Reports, 10(1), 12649. https://doi.org/10.1038/s41598-020-69291-6
   PubMed Web of Science ®Google Scholar
• Luykx, J. J., Loef, D., Lin, B., van Diermen, L., Nuninga, J. O., van Exel, E., Oudega, M. L., Rhebergen, D., Schouws, S. N., van Eijndhoven, P., Verwijk, E., Schrijvers, D., Birkenhager, T. K., Ryan, K. M., Arts, B., van Bronswijk, S. C., Kenis, G., Schurgers, G., Baune, B. T., … Rutten, B. P. (2022). Interrogating associations between polygenic liabilities and electroconvulsive therapy effectiveness. Biological Psychiatry, 91(6), 531–539. https://doi.org/10.1016/j.biopsych.2021.10.013
   PubMed Web of Science ®Google Scholar
• Maj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., Demyttenaere, K., McIntyre, R. S., Widiger, T., & Wittchen, H.-U. (2020). The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry, 19(3), 269–293. https://doi.org/10.1002/wps.20771
   PubMed Web of Science ®Google Scholar
• Marshe, V. S., Maciukiewicz, M., Hauschild, A.-C., Islam, F., Qin, L., Tiwari, A. K., Sibille, E., Blumberger, D. M., Karp, J. F., Flint, A. J., Turecki, G., Lam, R. W., Milev, R. V., Frey, B. N., Rotzinger, S., Foster, J. A., Kennedy, S. H., Kennedy, J. L., Mulsant, B. H., … Müller, D. J. (2021). Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. Translational Psychiatry, 11(1), 127. https://doi.org/10.1038/s41398-021-01248-3
   PubMed Web of Science ®Google Scholar
• McIntyre, R. S., Filteau, M.-J., Martin, L., Patry, S., Carvalho, A., Cha, D. S., Barakat, M., & Miguelez, M. (2014). Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach. Journal of Affective Disorders, 156, 1–7. https://doi.org/10.1016/j.jad.2013.10.043
   PubMed Web of Science ®Google Scholar
• Meerman, J. J., ter Hark, S. E., Janzing, J. G. E., & Coenen, M. J. H. (2022). The potential of polygenic risk scores to predict antidepressant treatment response in major depression: A systematic review. Journal of Affective Disorders, 304, 1–11. https://doi.org/10.1016/j.jad.2022.02.015
   PubMed Web of Science ®Google Scholar
• Mistry, S., Escott-Price, V., Florio, A. D., Smith, D. J., & Zammit, S. (2019). Investigating associations between genetic risk for bipolar disorder and cognitive functioning in childhood. Journal of Affective Disorders, 259, 112–120. https://doi.org/10.1016/j.jad.2019.08.040
   PubMed Web of Science ®Google Scholar
• Murray, G. K., Lin, T., Austin, J., McGrath, J. J., Hickie, I. B., & Wray, N. R. (2021). Could polygenic risk scores be useful in psychiatry? A review. JAMA Psychiatry, 78(2), 210–219. https://doi.org/10.1001/jamapsychiatry.2020.3042
   PubMed Web of Science ®Google Scholar
• Pain, O., Dudbridge, F., Cardno, A. G., Freeman, D., Lu, Y., Lundstrom, S., Lichtenstein, P., & Ronald, A. (2018). Genome‐wide analysis of adolescent psychotic‐like experiences shows genetic overlap with psychiatric disorders. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177(4), 416–425. https://doi.org/10.1002/ajmg.b.32630
   PubMed Web of Science ®Google Scholar
• Pardiñas, A. F., Smart, S. E., Willcocks, I. R., Holmans, P. A., Dennison, C. A., Lynham, A. J., Legge, S. E., Baune, B. T., Bigdeli, T. B., Cairns, M. J., Corvin, A., Fanous, A. H., Frank, J., Kelly, B., McQuillin, A., Melle, I., Mortensen, P. B., Mowry, B. J., Pato, C. N., … Vázquez-Bourgon, J. (2022). Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia. JAMA Psychiatry, 79(3), 260–269. https://doi.org/10.1001/jamapsychiatry.2021.3799
   PubMed Web of Science ®Google Scholar
• Parker, G., & Brotchie, H. (2010). Gender differences in depression. International Review of Psychiatry, 22(5), 429–436. https://doi.org/10.3109/09540261.2010.492391
   PubMed Web of Science ®Google Scholar
• Pato, M. T., Sobell, J. L., Medeiros, H., Abbott, C., Sklar, B. M., Buckley, P. F., Bromet, E. J., Escamilla, M. A., Fanous, A. H., Lehrer, D. S., Macciardi, F., Malaspina, D., McCarroll, S. A., Marder, S. R., Moran, J., Morley, C. P., Nicolini, H., Perkins, D. O., Purcell, S. M., … Pato, C. N. (2013). The genomic psychiatry cohort: Partners in discovery. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162(4), 306–312. https://doi.org/10.1002/ajmg.b.32160
   Google Scholar
• Pence, A. Y., Pries, L. K., Ferrara, M., Rutten, B. P. F., van Os, J., & Guloksuz, S. (2022). Gender differences in the association between environment and psychosis. Schizophrenia Research, 243, 120–137. https://doi.org/10.1016/j.schres.2022.02.039
   PubMed Web of Science ®Google Scholar
• Popejoy, A. B., & Fullerton, S. M. (2016). Genomics is failing on diversity. Nature, 538(7624), 161–164. https://doi.org/10.1038/538161a
   PubMed Web of Science ®Google Scholar
• Pries, L.-K., Dal Ferro, G. A., van Os, J., Delespaul, P., Kenis, G., Lin, B. D., Luykx, J. J., Richards, A. L., Akdede, B., Binbay, T., Altınyazar, V., Yalınçetin, B., Gümüş-Akay, G., Cihan, B., Soygür, H., Ulaş, H., Şahin Cankurtaran, E., Ulusoy Kaymak, S., Mihaljevic, M. M., … Guloksuz, S. (2020). Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum. Epidemiology and Psychiatric Sciences, 29, e182. https://doi.org/10.1017/S2045796020000943
   PubMed Web of Science ®Google Scholar
• Pries, L.-K., Erzin, G., van Os, J., ten Have, M., de Graaf, R., van Dorsselaer, S., Bak, M., Rutten, B. P. F., & Guloksuz, S. (2021). Predictive performance of exposome score for schizophrenia in the general population. Schizophrenia Bulletin, 47(2), 277–283. https://doi.org/10.1093/schbul/sbaa170
   PubMed Web of Science ®Google Scholar
• Pries, L.-K., Lage-Castellanos, A., Delespaul, P., Kenis, G., Luykx, J. J., Lin, B. D., Richards, A. L., Akdede, B., Binbay, T., Altinyazar, V., Yalinçetin, B., Gümüş-Akay, G., Cihan, B., Soygür, H., Ulaş, H., Cankurtaran, E. Ş., Kaymak, S. U., Mihaljevic, M. M., Petrovic, S. A., … Guloksuz, S. (2019). Estimating exposome score for schizophrenia using predictive modeling approach in two independent samples: The results from the EUGEI Study. Schizophrenia Bulletin, 45(5), 960–965. https://doi.org/10.1093/schbul/sbz054
   PubMed Web of Science ®Google Scholar
• Pries, L.-K., van Os, J., Ten Have, M., de Graaf, R., van Dorsselaer, S., Bak, M., Lin, B. D., van Eijk, K. R., Kenis, G., Richards, A., O’Donovan, M. C., Luykx, J. J., Rutten, B. P. F., & Guloksuz, S. (2020). Association of recent stressful life events with mental and physical health in the context of genomic and exposomic liability for schizophrenia. JAMA Psychiatry, 77(12), 1296–1304. https://doi.org/10.1001/jamapsychiatry.2020.2304
   PubMed Web of Science ®Google Scholar
• Reich, D. E., & Lander, E. S. (2001). On the allelic spectrum of human disease. Trends in Genetics, 17(9), 502–510. https://doi.org/10.1016/S0168-9525(01)02410-6
   PubMed Web of Science ®Google Scholar
• Ruderfer, D. M., Charney, A. W., Readhead, B., Kidd, B. A., Kähler, A. K., Kenny, P. J., Keiser, M. J., Moran, J. L., Hultman, C. M., Scott, S. A., Sullivan, P. F., Purcell, S. M., Dudley, J. T., & Sklar, P. (2016). Polygenic overlap between schizophrenia risk and antipsychotic response: A genomic medicine approach. The Lancet. Psychiatry, 3(4), 350–357. https://doi.org/10.1016/S2215-0366(15)00553-2
   PubMed Web of Science ®Google Scholar
• Schubert, K. O., Thalamuthu, A., Amare, A. T., Frank, J., Streit, F., Adl, M., Akula, N., Akiyama, K., Ardau, R., Arias, B., Aubry, J.-M., Backlund, L., Bhattacharjee, A. K., Bellivier, F., Benabarre, A., Bengesser, S., Biernacka, J. M., Birner, A., Marie-Claire, C., … Baune, B. T. (2021). Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. Translational Psychiatry, 11(1), 606. https://doi.org/10.1038/s41398-021-01702-2
   Web of Science ®Google Scholar
• Shah, J. L., Jones, N., van Os, J., McGorry, P. D., & Gülöksüz, S. (2022). Early intervention service systems for youth mental health: Integrating pluripotentiality, clinical staging, and transdiagnostic lessons from early psychosis. The Lancet. Psychiatry, 9(5), 413–422. https://doi.org/10.1016/S2215-0366(21)00467-3
   PubMed Web of Science ®Google Scholar
• Singh, T., Poterba, T., Curtis, D., Akil, H., Al Eissa, M., Barchas, J. D., Bass, N., Bigdeli, T. B., Breen, G., Bromet, E. J., Buckley, P. F., Bunney, W. E., Bybjerg-Grauholm, J., Byerley, W. F., Chapman, S. B., Chen, W. J., Churchhouse, C., Craddock, N., Cusick, C. M., … Daly, M. J. (2022). Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature, 604(7906), 509–516. https://doi.org/10.1038/s41586-022-04556-w
   PubMed Web of Science ®Google Scholar
• Smoller, J. W., Andreassen, O. A., Edenberg, H. J., Faraone, S. V., Glatt, S. J., & Kendler, K. S. (2019). Psychiatric genetics and the structure of psychopathology. Molecular Psychiatry, 24(3), 409–420. https://doi.org/10.1038/s41380-017-0010-4
   PubMed Web of Science ®Google Scholar
• Suwinski, P., Ong, C., Ling, M. H., Poh, Y. M., Khan, A. M., & Ong, H. S. (2019). Advancing personalized medicine through the application of whole exome sequencing and big data analytics. Frontiers in Genetics, 10, 49. https://doi.org/10.3389/fgene.2019.00049
   PubMed Web of Science ®Google Scholar
• Tansey, K. E., Guipponi, M., Domenici, E., Lewis, G., Malafosse, A., O’Donovan, M., Wendland, J. R., Lewis, C. M., McGuffin, P., & Uher, R. (2014). Genetic susceptibility for bipolar disorder and response to antidepressants in major depressive disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 165(1), 77–83. https://doi.org/10.1002/ajmg.b.32210
   Web of Science ®Google Scholar
• Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., Bryois, J., Chen, C.-Y., Dennison, C. A., Hall, L. S., Lam, M., Watanabe, K., Frei, O., Ge, T., Harwood, J. C., Koopmans, F., Magnusson, S., Richards, A. L., Sidorenko, J., … van Os, J. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502–508. https://doi.org/10.1038/s41586-022-04434-5
   PubMed Web of Science ®Google Scholar
• van Diermen, L., van den Ameele, S., Kamperman, A. M., Sabbe, B. C. G., Vermeulen, T., Schrijvers, D., & Birkenhäger, T. K. (2018). Prediction of electroconvulsive therapy response and remission in major depression: Meta-analysis. The British Journal of Psychiatry, 212(2), 71–80. https://doi.org/10.1192/bjp.2017.28
   PubMed Web of Science ®Google Scholar
• van Os, J., Kenis, G., & Rutten, B. P. (2010). The environment and schizophrenia. Nature, 468(7321), 203–212. https://doi.org/10.1038/nature09563
   PubMed Web of Science ®Google Scholar
• Wagner, E., Siafis, S., Fernando, P., Falkai, P., Honer, W. G., Röh, A., Siskind, D., Leucht, S., & Hasan, A. (2021). Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review. Translational Psychiatry, 11(1), 1–18. https://doi.org/10.1038/s41398-021-01613-2
   PubMed Web of Science ®Google Scholar
• Wand, H., Lambert, S. A., Tamburro, C., Iacocca, M. A., O’Sullivan, J. W., Sillari, C., Kullo, I. J., Rowley, R., Dron, J. S., Brockman, D., Venner, E., McCarthy, M. I., Antoniou, A. C., Easton, D. F., Hegele, R. A., Khera, A. V., Chatterjee, N., Kooperberg, C., Edwards, K., … Wojcik, G. L. (2021). Improving reporting standards for polygenic scores in risk prediction studies. Nature, 591(7849), 211–219. https://doi.org/10.1038/s41586-021-03243-6
   PubMed Web of Science ®Google Scholar
• Ward, J., Graham, N., Strawbridge, R. J., Ferguson, A., Jenkins, G., Chen, W., Hodgson, K., Frye, M., Weinshilboum, R., Uher, R., Lewis, C. M., Biernacka, J., & Smith, D. J. (2018). Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts. PLoS One, 13(9), e0203896. https://doi.org/10.1371/journal.pone.0203896
   PubMed Web of Science ®Google Scholar
• Werner, M. C. F., Wirgenes, K. V., Haram, M., Bettella, F., Lunding, S. H., Rødevand, L., Hjell, G., Agartz, I., Djurovic, S., Melle, I., Andreassen, O. A., & Steen, N. E. (2020). Indicated association between polygenic risk score and treatment-resistance in a naturalistic sample of patients with schizophrenia spectrum disorders. Schizophrenia Research, 218, 55–62. https://doi.org/10.1016/j.schres.2020.03.006
   PubMed Web of Science ®Google Scholar
• Wigmore, E. M., Hafferty, J. D., Hall, L. S., Howard, D. M., Clarke, T.-K., Fabbri, C., Lewis, C. M., Uher, R., Navrady, L. B., Adams, M. J., Zeng, Y., Campbell, A., Gibson, J., Thomson, P. A., Hayward, C., Smith, B. H., Hocking, L. J., Padmanabhan, S., Deary, I. J., … McIntosh, A. M. (2020). Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP. The Pharmacogenomics Journal, 20(2), 329–341. https://doi.org/10.1038/s41397-019-0067-3
   PubMed Web of Science ®Google Scholar
• Wild, C. P. (2005). Complementing the genome with an “exposome”: The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiology, Biomarkers & Prevention, 14(8), 1847–1850. https://doi.org/10.1158/1055-9965.EPI-05-0456
   PubMed Web of Science ®Google Scholar
• Wild, C. P. (2012). The exposome: From concept to utility. International Journal of Epidemiology, 41(1), 24–32. https://doi.org/10.1093/ije/dyr236
   PubMed Web of Science ®Google Scholar
• Wimberley, T., Gasse, C., Meier, S. M., Agerbo, E., MacCabe, J. H., & Horsdal, H. T. (2017). Polygenic risk score for schizophrenia and treatment-resistant schizophrenia. Schizophrenia Bulletin, 43(5), 1064–1069. https://doi.org/10.1093/schbul/sbx007
   PubMed Web of Science ®Google Scholar
• Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., Alda, M., MacQueen, G., Milev, R. V., Ravindran, A., O’Donovan, C., McIntosh, D., Lam, R. W., Vazquez, G., Kapczinski, F., … Berk, M. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97–170. https://doi.org/10.1111/bdi.12609
   PubMed Web of Science ®Google Scholar
• Zhang, J. P., & Malhotra, A. K. (2018). Recent progress in pharmacogenomics of antipsychotic drug response. Current Psychiatry Reports, 20(4), 24. https://doi.org/10.1007/s11920-018-0886-y
   PubMed Web of Science ®Google Scholar
• Zhang, J.-P., Robinson, D., Yu, J., Gallego, J., Fleischhacker, W. W., Kahn, R. S., Crespo-Facorro, B., Vazquez-Bourgon, J., Kane, J. M., Malhotra, A. K., & Lencz, T. (2019). Schizophrenia polygenic risk score as a predictor of antipsychotic efficacy in first-episode psychosis. American Journal of Psychiatry, 176(1), 21–28. https://doi.org/10.1176/appi.ajp.2018.17121363
   PubMed Web of Science ®Google Scholar